Stories of Survival: Brian Galgay and Karen Kent

Patients in the CARTITUDE-4 trial experienced a high response rate to the treatment as early as their first relapse.

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

Older patients with cancer demonstrated a moderate to high symptom burden, leading to the need for routine symptom assessments and tailored management interventions.

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

Oncology nurses can educate their patients on the latest developments in CAR T-cell therapy for the treatment of glioblastoma.

An expert discussed a screening tool that she and her colleagues used to connect patients with cancer to palliative care services in a more effective way.